Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease. [electronic resource]
- Clinical rheumatology Feb 2019
- 609-610 p. digital
Publication Type: Letter
1434-9949
10.1007/s10067-018-4357-y doi
Adult Antibodies, Monoclonal, Humanized--therapeutic use Arthralgia--etiology Female Gastrointestinal Agents--therapeutic use Humans Inflammatory Bowel Diseases--drug therapy Male Middle Aged Recurrence Spondylarthritis--etiology